TLS11a Aptamer/CD3 Antibody Anti-Tumor System for Liver Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TLS11a Aptamer/CD3 Antibody Anti-Tumor System for Liver Cancer

Published:2018-09-01 Issue:9 Volume:14 Page:1645-1653
ISSN:1550-7033
Container-title:Journal of Biomedical Nanotechnology
language:en
Short-container-title:j biomed nanotechnol

Author:

Hu Zixi,He Jian,Gong Wenlin,Zhou Nuo,Zhou Sufang,Lai Zongqiang,Zheng Rong,Wang Yiwei,Yang Xiaomei,Yang Wei,Zhong Liping,Lu Xiaoling,Zhao Yongxiang

Publisher

American Scientific Publishers

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication and characterization of starch/agarose biopolymers containing graphene oxide towards the release of 5-fluorouracil in cancer treatment;Inorganic Chemistry Communications;2024-09

2. The Application of Aptamer and Research Progress in Liver Disease;Molecular Biotechnology;2024-02-02

3. Aptamer-Based Smart Targeting and Spatial Trigger–Response Drug-Delivery Systems for Anticancer Therapy;Biomedicines;2024-01-15

4. Novel nanotherapeutics for cancer immunotherapy by albumin nanoparticles functionalized with PD-1 and PD-L1 aptamers;Cancer Nanotechnology;2024-01-06

5. Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p;Advanced Science;2023-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP